DFX Intelligence
Frazier Life Sciences X, L.P.
As of · the latest observation of this vehicle; each figure below carries its own filing date
Active deploymentFundraising status unknownADV: Private Equity Fund
As of · the latest observation of this vehicle; each figure below carries its own filing date
6 additional placement agents
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- +38%reported GAV
Reported gross assets rose from $567M to $781M between the Form ADV filings of 30 Mar 2024 and 31 Mar 2026.
The fund's assets as the adviser swears them, never its size or dry powder.
Drawing the relationship network…
Amounts, each with its basis
- Vintage
- 2022basis: adv first reported
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- $617Mwhat may be sold, not what was raised; file 021-355633, sworn by the adviser or filed under this vehicle
- Form D sold
- $0as of the filing of Dec 17, 2019
- First sale
- unknown
- Reported GAV
- $781Mon the Form ADV filed Mar 31, 2026; the fund's assets, never its size or dry powder
- Owners (ADV)
- 72
- Reported on ADV
- Mar 31, 2022 to Mar 31, 2026
Fundraising evidence
What counts as raisingA Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.Unknown
latest Form D 2019-12-17, older than 15 months (fr-1)
evidence dated Dec 17, 2019.
Lifecycle
Active deployment
Lifecycle
vintage 2 to 4 years
age years: 4first sale: n/avintage year: 2022adv gav as of: Mar 31, 2026vintage basis: ADV first reportedform d sold: $0form d offering: $617Mform d latest filed at: Dec 17, 2019
The fund's own reporting through time
8 Form ADV filings
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Mar 30, 2020 | Venture Capital Fund | $617M | 71 | $3.0M | 3% | yes | |
| Mar 31, 2021 | Venture Capital Fund | $708M | 73 | $3.0M | 3% | yes | |
| Nov 2, 2021 | Venture Capital Fund | $708M | 73 | $3.0M | 3% | yes | |
| Mar 31, 2022 | Venture Capital Fund | $642M | 73 | $3.0M | 3% | yes | |
| Mar 31, 2023 | Private Equity Fund | $667M | 73 | $3.0M | 3% | yes | |
| Jan 12, 2024 | Private Equity Fund | $667M | 73 | $3.0M | 3% | yes | |
| Mar 30, 2024 | Private Equity Fund | $567M | 72 | $3.0M | 3% | yes | |
| Mar 31, 2026 | Private Equity Fund | $781M | 72 | $3.0M | 3% |
Principals and agents
2 principals on Form D, 0 placement agents
- Patrick J. Heron Executive Officer
- James N. Topper Executive Officer
Service providers
9 named on Form ADV Schedule D and Form D
- AuditorDeloitte · SEATTLE, Washington, United StatesForm ADV filed Mar 31, 2026 reports.adviserinfo.sec.gov
- CustodianBROADRIDGE CORPORATE ISSUE SOLUTIONS · EDGEWOOD, New York, United StatesForm ADV filed Mar 31, 2026 reports.adviserinfo.sec.gov
- CustodianCOMPUTERSHARE TRUST COMPANY, N.A. · CANTON, Massachusetts, United StatesForm ADV filed Mar 31, 2026 reports.adviserinfo.sec.gov
Limited partners and their reported performance
Whose numbers these areEach row is the LP’s own number: its cash flows and its valuation policy as of its reporting date, not the fund’s. Net IRR is printed only when the LP prints one. The vintage is the LP’s definition (CalPERS: year of its first cash flow; WSIB: year of its initial investment).0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Known LPs and allocators
What these amounts and dates areA commitment date prints only when the source printed one; otherwise the row carries the date of the report that listed it. A foundation’s 990-PF line is a holding at fair value on its return, never a commitment.0 relationships, public pensions and the allocator graph, each counted once
No allocator names this vehicle in a public disclosure DFX holds: pension reports, foundation 990-PF returns or endowment disclosures.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
3 events
- Mar 31, 2022Frazier Life Sciences X, L.P. no longer reported on Form ADV by Frazier Healthcare PartnersFund no longer reported Inference Form ADV
- Mar 30, 2020Frazier Life Sciences X, L.P. first reported on Form ADV by Frazier Healthcare Partners (Venture Capital Fund), GAV $617,050,000Fund first reported on Form ADV Fact Form ADV
- Dec 17, 2019Frazier Life Sciences X, L.P. filed Form D: no sales yet of $617,050,000, Venture Capital FundForm D filed Fact Form D
Evidence
30 observations
Every observation on this vehicle
- Entity type: Limited Partnership Fact Form D
- Entity type: Limited Partnership Dec 17, 2019 Fact Form D
- Form D fund type: Venture Capital Fund Fact Form D
- Form D fund type: Venture Capital Fund Dec 17, 2019 Fact Form D
- Form D industry group: Pooled Investment Fund Fact Form D
- Form D industry group: Pooled Investment Fund Dec 17, 2019 Fact Form D
- Amendment: false Fact Form D
- Amendment: false Dec 17, 2019 Fact Form D
- Revenue range (Form D): Not Applicable Fact Form D
- Revenue range (Form D): Not Applicable Dec 17, 2019 Fact Form D
- Incorporated: withinFiveYears Fact Form D
- Incorporated: withinFiveYears Dec 17, 2019 Fact Form D
- Jurisdiction: Delaware Fact Form D
- Jurisdiction: Delaware Dec 17, 2019 Fact Form D
- Amount sold (Form D): $0 Fact Form D
- Amount sold (Form D): $0 Dec 17, 2019 Fact Form D
- Offering amount (Form D): $617M Fact Form D
- Offering amount (Form D): $617M Dec 17, 2019 Fact Form D
- Exemptions: 06b, 3C, 3C.7 Fact Form D
- Exemptions: 06b, 3C, 3C.7 Dec 17, 2019 Fact Form D
- Investors (Form D): 0 Fact Form D
- Investors (Form D): 0 Dec 17, 2019 Fact Form D
- Minimum investment (Form D): 0 Fact Form D
- Minimum investment (Form D): 0 Dec 17, 2019 Fact Form D
- Securities offered: pooled Fact Form D
- Securities offered: pooled Dec 17, 2019 Fact Form D
- Office address: Fact Form D
- Office address: Dec 17, 2019 Fact Form D
- Year of incorporation: 2019 Fact Form D
- Year of incorporation: 2019 Dec 17, 2019 Fact Form D
Relationships across DFX
on 4 other DFX graphs
Across the graphs
Frazier Life Sciences X, L.P. is the same institution as 5 records in Private Equity, Allocators, RIA and Wealth and Family Offices.
Private Equity2Allocators1RIA and Wealth1Family Offices1
DFX found 5 relationships across 4 datasets
Which record it is in each graph, what it is called there, and how the two were matched.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Checking your plan…
Record history
3 dated events on the change ledger, latest event first
- Fund dropped from ADV2022-03-31source on record
- Fund first reported on ADV2020-03-30source on record
- Form D filed2019-12-17source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.